1. Home
  2. GNTA vs YI Comparison

GNTA vs YI Comparison

Compare GNTA & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$0.63

Market Cap

31.8M

Sector

Health Care

ML Signal

HOLD

YI

111 Inc.

HOLD

Current Price

$3.13

Market Cap

30.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNTA
YI
Founded
2014
2010
Country
Italy
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
31.8M
30.8M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
GNTA
YI
Price
$0.63
$3.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 54.0K
12.5K
Earning Date
03-24-2026
09-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$36.96
Revenue Next Year
N/A
$14.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.55
$2.48
52 Week High
$10.00
$11.17

Technical Indicators

Market Signals
Indicator
GNTA
YI
Relative Strength Index (RSI) 38.27 39.58
Support Level $0.59 $2.68
Resistance Level $0.68 $4.08
Average True Range (ATR) 0.06 0.16
MACD 0.01 -0.00
Stochastic Oscillator 24.75 15.79

Price Performance

Historical Comparison
GNTA
YI

About GNTA Genenta Science S.p.A.

Genenta Science SPA is an industrial consolidator focused on acquiring majority or full ownership of privately held, established companies operating in Italian national-security-regulated sectors. Its acquisition activities span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity, with a focus on businesses covered by Italy's Golden Power legislation.

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: